Skip to content
10-Q

Quarterly Report

CORCEPT THERAPEUTICS INC CORT

0001628280-25-037005

← back to feed
Filed
Jul 31, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jul 24, 2025 105.37M sh
Shares Diluted Q2 2025 · Jun 30, 2025 120.49M sh
Shares Diluted Q2 2025 · Jun 30, 2025 120.23M sh
Shares Diluted Q2 2025 · Jun 30, 2024 111.24M sh
Shares Diluted Q2 2025 · Jun 30, 2024 110.55M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $130.45M
Stock Repurchased Q2 2025 · Jun 30, 2024 $3.95M
Capex Q2 2025 · Jun 30, 2025 $161K
Capex Q2 2025 · Jun 30, 2024 $416K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $49.07M
Operating Cash Flow restated Q2 2025 · Jun 30, 2024 $64.94M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $102.75M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $127.67M
Stockholders Equity Q2 2025 · Jun 30, 2025 $635.79M
Stockholders Equity Q2 2025 · Mar 31, 2025 $683.29M
Stockholders Equity Q2 2025 · Dec 31, 2024 $679.59M
Stockholders Equity Q2 2025 · Jun 30, 2024 $596.24M
Stockholders Equity Q2 2025 · Mar 31, 2024 $547.86M
Stockholders Equity Q2 2025 · Dec 31, 2023 $506.71M
Current Liabilities Q2 2025 · Jun 30, 2025 $144.66M
Current Liabilities Q2 2025 · Dec 31, 2024 $140.77M
Total Liabilities Q2 2025 · Jun 30, 2025 $165.93M
Total Liabilities Q2 2025 · Dec 31, 2024 $160.96M
Current Assets Q2 2025 · Jun 30, 2025 $443.11M
Current Assets Q2 2025 · Dec 31, 2024 $471.6M
Total Assets Q2 2025 · Jun 30, 2025 $801.72M
Total Assets Q2 2025 · Dec 31, 2024 $840.55M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.29
Eps Diluted Q2 2025 · Jun 30, 2025 $0.46
Eps Diluted Q2 2025 · Jun 30, 2024 $0.32
Eps Diluted Q2 2025 · Jun 30, 2024 $0.57
Eps Basic Q2 2025 · Jun 30, 2025 $0.33
Eps Basic Q2 2025 · Jun 30, 2025 $0.53
Eps Basic Q2 2025 · Jun 30, 2024 $0.34
Eps Basic Q2 2025 · Jun 30, 2024 $0.61
Sga Expense Q2 2025 · Jun 30, 2025 $103.85M
Sga Expense Q2 2025 · Jun 30, 2025 $194.51M
Sga Expense Q2 2025 · Jun 30, 2024 $66.94M
Sga Expense Q2 2025 · Jun 30, 2024 $123.2M
Rd Expense Q2 2025 · Jun 30, 2025 $60.47M
Rd Expense Q2 2025 · Jun 30, 2025 $121.21M
Rd Expense Q2 2025 · Jun 30, 2024 $58.75M
Rd Expense Q2 2025 · Jun 30, 2024 $117.25M
Net Income Q2 2025 · Jun 30, 2025 $35.15M
Net Income Q2 2025 · Jun 30, 2025 $55.7M
Net Income Q2 2025 · Mar 31, 2025 $20.55M
Net Income Q2 2025 · Jun 30, 2024 $35.49M
Net Income Q2 2025 · Jun 30, 2024 $63.25M
Net Income Q2 2025 · Mar 31, 2024 $27.76M
Operating Income Q2 2025 · Jun 30, 2025 $26.68M
Operating Income Q2 2025 · Jun 30, 2025 $30.09M
Operating Income Q2 2025 · Jun 30, 2024 $35.59M
Operating Income Q2 2025 · Jun 30, 2024 $65.09M
Revenue Q2 2025 · Jun 30, 2025 $194.43M
Revenue Q2 2025 · Jun 30, 2025 $351.64M
Revenue Q2 2025 · Jun 30, 2024 $163.8M
Revenue Q2 2025 · Jun 30, 2024 $310.6M